Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials
- PMID: 31004628
- PMCID: PMC6584030
- DOI: 10.1016/j.neubiorev.2019.03.023
Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials
Abstract
With growing interest in the gut microbiome, prebiotics and probiotics have received considerable attention as potential treatments for depression and anxiety. We conducted a random-effects meta-analysis of 34 controlled clinical trials evaluating the effects of prebiotics and probiotics on depression and anxiety. Prebiotics did not differ from placebo for depression (d = -.08, p = .51) or anxiety (d = .12, p = .11). Probiotics yielded small but significant effects for depression (d = -.24, p < .01) and anxiety (d = -.10, p = .03). Sample type was a moderator for probiotics and depression, with a larger effect observed for clinical/medical samples (d = -.45, p < .001) than community ones. This effect increased to medium-to-large in a preliminary analysis restricted to psychiatric samples (d = -.73, p < .001). There is general support for antidepressant and anxiolytic effects of probiotics, but the pooled effects were reduced by the paucity of trials with clinical samples. Additional randomized clinical trials with psychiatric samples are necessary fully to evaluate their therapeutic potential.
Keywords: Anxiety; Depression; Microbiome; Prebiotic; Probiotic.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Figures
References
-
- Akkasheh G, Kashani-Poor Z, Tajabadi-Ebrahimi M, Jafari P, Akbari H, Taghizadeh M, Memarzadeh MR, Asemi Z, Esmaillzadeh A, 2016. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Nutrition 32, 315–320. 10.1016/j.nut.2015.09.003 - DOI - PubMed
-
- Azpiroz F, Dubray C, Bernalier-Donadille A, Cardot J-M, Accarino A, Serra J, Wagner A, Respondek F, Dapoigny M, 2017. Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: A randomized, double blind, placebo controlled study. Neurogastroenterol. Motil 29, e12911 10.1111/nmo.12911 - DOI - PubMed
-
- Biostat, 2014. Comprehensive Meta-Analysis Version 3.
-
- Chung YC, Jin HM, Cui Y, Kim DS, Jung JM, Park J Il, Jung ES, Choi EK, Chae SW, 2014. Fermented milk of Lactobacillus helveticus IDCC3801 improves cognitive functioning during cognitive fatigue tests in healthy older adults. J. Funct. Foods 10, 465–474. 10.1016/j.jff.2014.07.007 - DOI
